Vermeire S, Rutgeerts P, Van Steen K, Joossens S, Claessens G, Pierik M, Peeters M, Vlietinck R
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
Gut. 2004 Jul;53(7):980-6. doi: 10.1136/gut.2003.034033.
Genome wide scans in inflammatory bowel disease (IBD) have indicated various susceptibility regions with replication of 16cen (IBD1), 12q (IBD2), 6p (IBD3), 14q11 (IBD4), and 3p21. As no linkage was previously found on IBD regions 3, 7, 12, and 16 in Flemish IBD families, a genome wide scan was performed to detect other susceptibility regions in this population.
A cohort of 149 IBD affected relative pairs, all recruited from the Northern Flemish part of Belgium, were genotyped using microsatellite markers at 12 cM intervals, and analysed by Genehunter non-parametric linkage software. All families were further genotyped for the three main Crohn's disease associated variants in the NOD2/CARD15 gene.
Nominal evidence for linkage was observed on chromosomes 1 (D1S197: multipoint non-parametric linkage (NPL) score 2.57, p = 0.004; and at D1S305-D1S252: NPL 2.97, p = 0.001), 4q (D4S406: NPL 1.95, p = 0.03), 6q16 (D6S314: NPL 2.44, p = 0.007), 10p12 (D10S197: NPL 2.05, p = 0.02), 11q22 (D11S35-D11S927: NPL 1.95, p = 0.02) 14q11-12 (D14S80: NPL 2.41, p = 0.008), 20p12 (D20S192: NPL 2.7, p = 0.003), and Xq (DXS990: NPL 1.70, p = 0.04). A total of 51.4% of patients carried at least one NOD2/CARD15 variant. Furthermore, epistasis was observed between susceptibility regions 6q/10p and 20p/10p.
Genome scanning in a Flemish IBD population found nominal evidence for linkage on 1p, 4q, 10p12, and 14q11, overlapping with other genome scan results, with linkage on 14q11-12 supporting the IBD4 locus. The results further show that epistasis is contributing to the complex model of IBD and indicate that population heterogeneity is not to be underestimated. Finally, NOD2/CARD15 is clearly implicated in the Flemish IBD population.
炎症性肠病(IBD)的全基因组扫描已表明存在多个易感区域,其中16cen(IBD1)、12q(IBD2)、6p(IBD3)、14q11(IBD4)和3p21区域已得到重复验证。由于此前在佛兰芒IBD家族的IBD区域3、7、12和16上未发现连锁关系,因此进行了全基因组扫描以检测该人群中的其他易感区域。
对来自比利时佛兰芒北部地区的149对受IBD影响的亲属进行队列研究,使用间隔为12 cM的微卫星标记进行基因分型,并通过Genehunter非参数连锁软件进行分析。对所有家族进一步进行NOD2/CARD15基因中三个主要克罗恩病相关变异的基因分型。
在染色体1(D1S197:多点非参数连锁(NPL)评分2.57,p = 0.004;以及在D1S305 - D1S252:NPL 2.97,p = 0.001)、4q(D4S406:NPL 1.95,p = 0.03)、6q16(D6S314:NPL 2.44,p = 0.007)、10p12(D10S197:NPL 2.05,p = 0.02)、11q22(D11S35 - D11S927:NPL 1.95,p = 0.02)、14q11 - 12(D14S80:NPL 2.41,p = 0.008)、20p12(D20S192:NPL 2.7,p = 0.003)和Xq(DXS990:NPL 1.70,p = 0.04)上观察到连锁的名义证据。共有51.4%的患者携带至少一种NOD2/CARD15变异。此外,在易感区域6q/10p和20p/10p之间观察到上位性。
在佛兰芒IBD人群中进行的基因组扫描发现了1p、4q、10p12和14q11上连锁的名义证据,与其他基因组扫描结果重叠,14q11 - 12上的连锁支持IBD4位点。结果进一步表明上位性促成了IBD的复杂模式,并表明人群异质性不可低估。最后,NOD2/CARD15显然与佛兰芒IBD人群有关。